Dsicover a recent study that compared Stockholm3 with other established biomarkers for prostate cancer screening. Learn more.

These include producing the fluid that nourishes and transports sperm, secreting prostate-specific antigen (PSA), a protein that helps semen retain its liquid state, and helping aid urine control.

Prostate cancer is one of the most frequently diagnosed cancers in men. Prostate tumor staging and disease aggressiveness are evaluated based on the Gleason scoring system, which is further used to ...

The trial team recruited men suspected of prostate cancer, based on either elevated prostate-specific antigen (PSA) or an abnormal digital rectal examination, to enroll in the study. None of the ...

which would not have been detected with prostate-specific antigen (PSA) testing or MRI. Prostate cancer remains the second most commonly diagnosed cancer among men. As a screening tool ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for trofolastat (RoTecPSMA), a prostate-specific membrane antigen (PSMA)-targeting agent for detecting ...

High-resolution microultrasonography-guided biopsy was non-inferior to MRI fusion-guided biopsy for detecting clinically significant prostate cancer (detection rates, 47.1% and 42.6%, respectively ...